This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
Subscribe To Our Newsletter & Stay Updated
